Endovascular Suturing Device to Improve Endograft Fixation in Abdominal Aortic Aneurysm
Official title: Endovascular Suturing Device for Augmentation of Endograft Fixation During Endovascular Repair of Abdominal Aortic Aneurysm to Reduce Reinterventions Due to Endograft Migration or Type 1a Endoleak
Funded at Vesteck, INC · NIH-11414951 · Data updated 2026-11-12
A new device aims to better secure endografts during EVAR for abdominal aortic aneurysm to reduce future repairs.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vesteck, INC NIH-funded |
| Lab location | 1 site (Malvern, UNITED STATES) |
| Project start | September 15, 2025 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $624,389 |
| NIH project number | 5R44HL178318-02 |
| Project ID | NIH-11414951 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with abdominal aortic aneurysm treated or being considered for EVAR who are eligible for a first-in-human feasibility study.
✕Less likely to help
Patients not eligible for the device trial or who have anatomy unsuitable for endograft anchoring may not benefit.
What this research studies
If you have an abdominal aortic aneurysm treated with an EVAR, this project tests a novel suturing device designed to attach the graft more securely to the aorta, with the goal of reducing graft movement and the need for later procedures. The team has already completed pre-clinical testing and is moving toward initial human use. If successful, the device could offer a safer, longer-lasting repair with fewer follow-up surgeries.
Why it matters
Potential benefit: If successful, patients could experience fewer reinterventions and better long-term outcomes after EVAR.
How similar studies have gone: Previous endograft anchoring approaches showed feasibility but had higher failure rates, making this novel device an important potential improvement.
Where this research is happening
-
Vesteck, INC
Malvern, United States Active
Researchers
- Principal investigator: Stalker, Kent — Vesteck, INC
- Study coordinator: Stalker, Kent
Related research
Other NIH-funded projects on the same topics.
-
How the small regulator miR-146a affects abdominal aortic aneurysm
This project aims to see if boosting a natural genetic regulator called miR-146a can help slow or prevent growth and rupture of abdominal aortic aneurysms in people with this condition.
-
MOF’s role in weakening the aorta and stopping aneurysm growth
Scientists are studying how a molecule called MOF and inflammatory signals affect abdominal aortic aneurysms to find ways to slow or stop their enlargement.
-
Triglyceride-rich lipoproteins and abdominal aortic aneurysm growth
A study exploring how fats in the blood (TRLs) influence the growth of abdominal aortic aneurysms to find non-surgical ways to protect against rupture, especially in people aged 65 and older.
-
Using genetics to uncover how abdominal aortic aneurysms develop
A research team will study how genetic differences influence abdominal aortic aneurysm to help with earlier prevention and better treatment.
-
Phospholipid-based nanotherapies to treat abdominal aortic aneurysm
A new nanoparticle treatment is being developed to slow or stop the growth of abdominal aortic aneurysms in adults.
-
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
A study to understand how a specific type of cell death in blood vessel walls may drive abdominal aortic aneurysm and if new targets could prevent rupture.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.